CTLA4 and brain neoplasm: Several studies reported the effectiveness of PD‐1 inhibitors such as nivolumab,6, 28 pembrolizumab,3, 29 and CTLA4 inhibitors (ipilimumab)3 in treating pediatric brain tumors associated with CMMRD.